missing translation for 'onlineSavingsMsg'
Learn More

Crizotinib, Tocris Bioscience™

Product Code. 18025362
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Potent c-MET/ALK inhibitor

Potent inhibitor of c-MET and anaplastic lymphoma kinase (ALK) (cell IC50 values are 8.0 and 20 nM respectively). Selective for c-MET and ALK against >120 different kinases. Displays antitumor efficacy in multiple tumor models; inhibits c-MET-dependent proliferation, migration and invasion of human tumor cells in vitro. Orally bioavailable.

Chemical Identifiers

CAS 877399-52-5
Molecular Formula C21H22Cl2FN5O
Molecular Weight (g/mol) 450.34
MDL Number MFCD12407409
InChI Key KTEIFNKAUNYNJU-UHFFFAOYNA-N
Synonym crizotinib, xalkori, r-crizotinib, crizotinibum, 3-1r-1-2,6-dichloro-3-fluorophenyl ethoxy-5-1-4-piperidinyl-1h-pyrazol-4-yl-2-pyridinamine, xalkori tn, r-3-1-2,6-dichloro-3-fluorophenyl ethoxy-5-1-piperidin-4-yl-1h-pyrazol-4-yl pyridin-2-amine, crizotinib pf-02341066, 3-1r-1-2,6-dichloro-3-fluorophenyl ethoxy-5-1-piperidin-4-yl-1h-pyrazol-4-yl pyridin-2-amine, crizotinib pf-2341066
PubChem CID 11626560
ChEBI CHEBI:64310
IUPAC Name 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine
SMILES CC(OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl

Specifications

Assay Percent Range >99%
Quantity 10 mg
Formula Weight 450.34
Chemical Name or Material Crizotinib
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.